NIAID awards more than $12 million for the development of antiviral therapies

Cloud technology with futuristic hologram on smartwatch

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, recently awarded more than $12 million to three institutions for the development of antiviral therapies to treat diseases caused by viruses with pandemic potential.

‘Butterfly bot’ swims 4X faster than past robots

Previous article

Researchers to develop brain imaging radiotracers for better understanding of Alzheimer’s, autism

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News